Solutions Architect, Lindus Health

Salary not provided

+ Stock Options

Senior and Expert level
London
Remote from US

More information about location

Lindus Health

Anti-CRO for life science pioneers

Job no longer available

Lindus Health

Anti-CRO for life science pioneers

101-200 employees

HealthcareB2BScienceMedTech

Job no longer available

Salary not provided

+ Stock Options

Senior and Expert level
London
Remote from US

More information about location

101-200 employees

HealthcareB2BScienceMedTech

Company mission

To improve the clinical research experience and build a better clinical research organization.

Company mission

To improve the clinical research experience and build a better clinical research organization.

Top investors

66% female employees

Our take

Traditional clinical research companies are often inefficient and rely upon pen and paper, even for the UK COVID-19 vaccine trial, one of the best-funded trials in history. In addition, the cost of conducting clinical trials has skyrocketed over the last decade. This, of course, stifles innovation and means fewer new treatments for patients.

In response to these challenges, Lindus Health was established with the mission to simplify patient participation in research and expedite the development of novel treatments. On a mission to change how trials are conducted in order to provide faster, safer clinical trials on behalf of companies developing new treatments, and lowering the barriers to participation for patients.

Since launching in 2021, Lindus Health has actively connected patients with clinical trials across diverse domains, encompassing areas such as type 2 diabetes, COVID-19 diagnostics, and mental health. Bolstered by several successful funding rounds, the company is poised to facilitate end-to-end clinical trials and research sponsors with high-quality data. Alongside this growth, Lindus is expanding its workforce. This strategic approach underscores its commitment to reshaping the landscape of clinical research for the betterment of patients and the advancement of medical science.

Kirsty headshot

Kirsty

Company Specialist at Welcome to the Jungle

Company values

  • Be transparent: We share information across the whole team, avoiding hierarchies and siloes. No politics!
  • Stay curious: Deference to "the way it has always been done" is the biggest thing holding our industry back
  • Be high-agency: Nothing happens unless we make it happen. We never assume something is somebody else's responsibility
  • Act quickly: Once we’ve made a decision. We win by moving fast
  • Benefit patients: Our mission is serious, but we’ll only achieve it if we have fun while we go. Innovation doesn’t take place in a boring environment

Funding (last 2 of 4 rounds)

Jan 2025

$55m

SERIES B

Aug 2023

$18m

SERIES A

Total funding: $78.7m

This company has top investors

Leadership

Meri Beckwith

(Co-Founder & Co-CEO)

Previously a venture capital investor and partner to biotech and digital health companies including Attest, Latent Logic, Helloself and CoMind.

Michael Young

(Co-Founder & Co-CEO)

Previously a Special Adviser to the UK Prime Minister, where they advised the UK government on life sciences. Also a former Management Consultant at McKinsey and LEK.

Lindus Health 1